EMA — Withdrawn Medicines & Recalls (FDA MedWatch)

EMA — Withdrawn Medicines & Recalls is the official source of medicine shortage information for United States (Americas). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.fda.gov

Country

United States

Notices tracked by Mederti

2,629

Last checked

8 Nov 2026

Latest notices from FDA MedWatch

• Argatroban Injection — active, critical, since 13 Oct 2026 (source)
• Cinacalcethydrochlorid — active, high, since 7 Oct 2026 (source)
• Abirtega (Abiraterone Acetate) Usp — active, high, since 6 Oct 2026 (source)
• Metoclopramide Tablets — active, high, since 6 Oct 2026 (source)
• Heparinised Saline Inj 10 Iu Per Ml, 5 Ml — active, high, since 1 Oct 2026 (source)
• Hydrocortisone-Hydrogen-Succinate — active, high, since 1 Oct 2026 (source)
• Telmisartan;Amlodipine — active, medium, since 1 Oct 2026 (source)
• Metoclopramide Tablets — active, high, since 29 Sept 2026 (source)
• Lidocaine Ointment Usp — active, high, since 28 Sept 2026 (source)
• Sermorelin — active, high, since 25 Sept 2026 (source)
• Tretinoin; Clindamycin — active, medium, since 25 Sept 2026 (source)
• Tirzepatide/Cyanocobalamin Injectable — active, high, since 24 Sept 2026 (source)
• Paroxetine — active, high, since 23 Sept 2026 (source)
• Imaavy Solution — active, high, since 23 Sept 2026 (source)
• Amazon — active, medium, since 18 Sept 2026 (source)

Mederti is not affiliated with or endorsed by EMA — Withdrawn Medicines & Recalls. All notices remain the property of their publisher and are linked to the original source.